Dr. Maurizio Fava is Chair of the Mass General Brigham AMC Psychiatry Department, executive director of the Massachusetts General Hospital (MGH) Clinical Trials Network and Institute (CTNI), and the Slater Family Professor of Psychiatry at Harvard Medical School. Dr. Fava is a world leader in the field of depression and clinical psychopharmacology. He has edited eight books and authored or co-authored more than 900 original articles published in medical journals with international circulation, articles which have been cited more than 115,000 times in the literature and with an h index greater than 165 on Google Scholar.

Dr. Fava obtained his medical degree from the University of Padova School of Medicine and completed residency training in endocrinology at the same university. He then moved to the United States and completed residency training in psychiatry at MGH. He founded and was director of the hospital’s Depression Clinical and Research Program from 1990 until 2014. Under Dr. Fava’s direction, the Depression Clinical and Research Program became one of the most highly regarded depression programs in the country, a model for academic programs that link, in a bi-directional fashion, clinical and research work. In 2007, he also founded and is now the executive director of the MGH Clinical Trials Network and Institute, the first academic CRO specialized in the coordination of multi-center clinical trials in psychiatry.

Dr. Fava has been successful in obtaining funding as principal or co-principal investigator from both the National Institutes of Health and other sources for a total of more than $150 million. Dr. Fava’s prominence in the field is reflected in his role as the co-principal investigator of STAR*D, the largest research study ever conducted in the area of depression, of the RAPID Network, the NIMH-funded series of studies of novel, rapidly-acting antidepressant therapies, and of the Clinical Coordinating Center of EPPIC-Net, the NINDS-funded network conducting proof-of-concept trials in pain. Dr. Fava is a well-known national and international lecturer, having given more than 300 presentations at national and international meetings. He is the former President of the American Society of Clinical Psychopharmacology and, in 2023, Dr. Fava was elected to the National Academy of Medicine.

Dr. Herman is Associate Chief of the Department of Psychiatry and Trustees Chair for Medical Psychiatry at MGH. He is Associate Professor of Psychiatry at Harvard Medical School .

Dr Herman sits on the Board of MGH’s Institute of Healthcare Professions and the Board of Massachusetts Medical Society’s Physician Health Service.

Dr. Herman is Medical Director of MGB’s Employee Assistance Program serving over 100,000+ employees and their family members. In addition to his active clinical practice, he supervises medical students and trainees and consults with clinical and administrative leaders regarding complex issues of interpersonal conflict and professionalism.

Dr Herman formerly served as Chair of the Massachusetts Board of Registration in Medicine and of its Quality and Patient Safety Committee, overseeing all licensed healthcare facilities in the Commonwealth.

Dr Herman received his undergraduate and medical degrees from the University of Wisconsin. After residency at MGH in 1984, Dr. Herman joined the staff of the MGH Psychopharmacology and Addiction clinics. An educator, for ten years he was Director the Adult Psychiatry Residency program and for 15 years, he directed the department’s national and international CME division. In. 2019 he received MGH’s  highest  physician honor Brian A. McGovern, MD Award for Clinical Excellence.

Dr. Janet Wozniak received her undergraduate degree from Harvard College where she graduated magna cum laude. During her medical school training at Cornell University Medical College, she earned a SmithKline Beckman Medical Perspectives Award for Outstanding Medical Students. Dr. Wozniak completed her adult and child psychiatry training at Massachusetts General Hospital (MGH). She has since received an Eli Lilly Pilot Research Award, the Elaine Schlosser Lewis Award and Claflin Distinguished Scholar Award. At MGH, she is the director of the Pediatric Bipolar Disorder Clinical and Research Program and the director of the Child and Adolescent Psychiatry Outpatient Service. She is also the Quality and Safety Chair for the Department of Psychiatry. She has received research funding from the National Institute of Mental Health, the Stanley Foundation, the National Alliance for Research in Schizophrenia and Depression, and the Heinz C. Prechter Fund for Manic Depression.

Dr. Wozniak’s research focuses on the characteristics, longitudinal course and treatment of pediatric bipolar disorder. She has addressed the frequent occurrence of pediatric bipolar disorder and its atypical presentation, and documented the high rates of comorbidity of pediatric bipolar disorder with other conditions such as attention deficit/hyperactivity disorder, conduct disorder, anxiety disorders and autism, as well as the frequency of occurrence of these disorders within families. Dr. Wozniak has completed one of the few longitudinal course studies of pediatric bipolar disorder, documenting high rates of persistence and the largest family study of the disorder.

Her treatment studies include an open label trial of omega-3 fatty acids (fish oil) for mania in children and the use of topiramate to offset weight gain associated with olanzapine treatment of children with bipolar disorder. Her current studies address the treatment of young children with omega-3 fatty acids and the natural treatment inositol, as well as the treatment of bipolar youth with the natural treatment N-acetylcysteine (NAC). Dr. Wozniak is a member of the Professional Advisory Council of organizations advocating for individuals with pediatric onset bipolar disorder, including the Balanced Mind Foundation, STEP up For Kids, the Ryan Licht Sang Foundation, and Ariel’s Legacy. Dr. Wozniak presents widely at national meetings devoted to psychiatric research including the American Psychiatric Association and the Association of Biological Psychiatry.

Dr. Wozniak’s 1995 paper on childhood mania is one of the ten most cited papers ever to be published in the Journal of the American Academy of Child and Adolescent Psychiatry. Widely regarded as a national expert on the topic of pediatric bipolar disorder and attention deficit/hyperactivity disorder, Dr. Wozniak is the author of dozens of scientific articles. She cares for hundreds of children and adolescents with these conditions in her clinical practice at MGH. She is the co-author of a book for parents published by Bantam Books titled, “Is Your Child Bipolar? The Definitive Resource on How to Identify, Treat and Thrive with a Bipolar Child.

Dr. Anthony Weiner is director of Outpatient Geriatric Psychiatry at Massachusetts General Hospital (MGH).  In 2016 he was selected as the inaugural incumbent of the Millicent and Eugene Bell Endowed Directorship in Older Adult Outpatient Psychiatry.  In addition, he has been selected as a Top Doctor in psychiatry by Boston Magazine for the last nine, consecutive years.

A clinician with more than 35 years of experience caring for older adult patients and their families, he is also an instructor in psychiatry at Harvard Medical School (HMS). His responsibilities include patient care, program development, teaching and research.

Dr. Weiner’s clinical practice involves caring for patients whose conditions intersect psychiatry, neurology and internal medicine, and whose care needs are often impacted by the presence of complicated polypharmacy, and a social network that is changing as the patient ages.

As a passionate advocate for improved mental health care for older adults, Dr. Weiner was recruited to Mass General in 2011 to build the Older Adult Outpatient Psychiatry Program. The program’s mission is to optimize the mental health and well-being of individuals age 65 and older who are affected by cognitive, mood or memory disorders through comprehensive, cross-disciplinary care, and to provide education and support to their families.

Dr. Weiner serves on the Outpatient Department Leadership Committee and is Project Lead of Care for America’s Aging, a first of its kind, clinical research project which aims to create a new and transformative model of homecare for the nation based on elevating and supporting the role of home health aides.

Before arriving at MGH in 2011, Dr. Weiner was a staff psychiatrist, Department of Psychiatry and Behavioral Medicine at Lahey Clinic performing office-based comprehensive evaluation and treatment visits of adult patients as well as providing psychiatric consultation to inpatients on the internal medicine and surgical services.

Dr. Weiner received his MD at Boston University. He began his medical training as an intern in internal medicine at Salem Hospital and completed his residency at the Massachusetts Mental Health Center as chief resident in psychiatry at the Palmer Five inpatient service at Deaconess Hospital. After completing his training, he was an attending psychiatrist with the Geriatric Medical-Psychiatric Service at Hallmark Health/Lawrence Memorial Hospital of Medford for over sixteen years. During this time, he was medical director of its Partial Hospitalization Program; director, Electroconvulsive Therapy (E.C.T.) Service; and, consultant, Nursing Home Consultation Service.  In addition, during these years, he also served as an inpatient attending and outpatient office-based psychiatrist. Dr. Weiner is board certified in psychiatry with the American Board of Psychiatry and Neurology.